Inseon S. Choi

Inseon S. Choi

Auto-generated profile, based on publicly available information

Inseon S. Choi

Department of Allergy, Chonnam National University Medical School and Research Institute of Medical Sciences, Gwangju, Korea

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
ICInseon S Choi
Inseon S Choi
Choi IS. Allergy Asthma Immunol Res. 2011 Apr;3(2):74-80. http://dx.doi.org/10.4168/aair.2011.3.2.74

1 January 2017 in The Korean Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
WKWoo-Jin Kim
Woo-Jin Kim
ICInseon S. Choi
Inseon S. Choi
CKChang Seong Kim
Chang Seong Kim
JLJeong-Hyeon Lee
Jeong-Hyeon Lee
HKHyeon-Wook Kang
Hyeon-Wook Kang
Mucosal immunoglobulin A (IgA) may prevent the entrance of allergens. This study examined the relationship between serum IgA levels (within the normal range) and sensitization to house dust mites (HDM) or airway hyper-responsiveness (AHR). The clinical records of 1,136 adult patients with suspected asthma, for whom test data for serum IgA level and methacholine-AHR were available, were reviewed retrospectively. The AHR/allergy indices were compared among patient groups with low (<140 mg/dL, group I), intermediate (140 to 280 mg/dL, group II), or high (≥280 mg/dL, group III) IgA levels in serum. The HDM skin sensitization rate progressively decreased from 30.0% in group I (n = 139) to 26.8% and 18.5% in groups II (n = 684) and III (n = 313), respectively (p = 0.003). Although both the HDM sensitization degree and the IgA level were significantly related to age, the adjusted odds ratio (OR) of association of a high IgA level (≥ 280 mg/dL) with HDM sensitization was significant (0.617; 95% confidence interval [CI], 0.415 to 0.916; p = 0.017). Among younger subjects (≤ 45 years of age) with AHR, the prevalence of moderate/severe AHR progressively decreased (70.6%, 52.3%, and 47.1% in groups I, II, and III [n = 34, 149, and 51]), respectively (p = 0.045). The IgA < 140 mg/dL was a significant risk factor for moderate/severe AHR (OR, 2.306; 95% CI, 1.049 to 5.071; p = 0.038). Sensitization to HDM and methacholine-AHR were significantly associated with serum IgA levels in suspected asthmatics, even when those levels were normal.

1 January 2012 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
ICInseon S. Choi
Inseon S. Choi
WKWon-Joo Ki
Won-Joo Ki
TKTae-Ock Kim
Tae-Ock Kim
EHEui-Ryoung Han
Eui-Ryoung Han
ISIl-Kook Seo
Il-Kook Seo
Choi IS, et al. Allergy Asthma Immunol Res. 2012 Jul;4(4):192-198. http://dx.doi.org/10.4168/aair.2012.4.4.192

1 January 2010 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
ICInseon S Choi
Inseon S Choi
EHEui-Ryoung Han
Eui-Ryoung Han
SLSeong-Wook Lim
Seong-Wook Lim
SLSeong-Ryoon Lim
Seong-Ryoon Lim
JKJi-Na Kim
Ji-Na Kim
YWYoung-Ho Won
Young-Ho Won
Choi IS, et al. Allergy Asthma Immunol Res. 2010 Apr;2(2):114-122. http://dx.doi.org/10.4168/aair.2010.2.2.114

23 September 2010 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
JLJin Sol Lee
Jin Sol Lee
JKJeong-Hyun Kim
Jeong-Hyun Kim
JBJoon Seol Bae
Joon Seol Bae
JKJason Yongha Kim
Jason Yongha Kim
TPTae Joon Park
Tae Joon Park
HSHyoung Doo Shin
Hyoung Doo Shin
Background: Aspirin-intolerant asthma (AIA) occurs in the lower and upper airways through excessive production of leukotrienes upon administration of non-steroidal anti-inflammatory drugs (NSAIDs). One of the three symptoms of AIA is nasal polyposis, a chronic inflammatory disease that is related to the function of calcium ion in recruitment of immune cells during airway inflammation. It has been implicated that bronchodilation in the airway is related to Ca(2+) regulation. The calcium channel, voltage-dependent, gamma subunit 6 (CACNG6) gene encodes a protein that stabilizes the calcium channel. Methods: To study the associations between AIA and polymorphisms in CACNG6 gene, eight variants were genotyped in 102 AIA cases and 429 aspirin-tolerant asthma (ATA) controls. Logistic analyses were used to evaluate the associations of CACNG6 polymorphisms with AIA. Results: Statistical analyses revealed that a single nucleotide polymorphism (SNP; rs192808C > T; P = 0.0004, P corr = 0.0029, OR = 2.88 in co-dominant model; P = 0.0005, P corr = 0.0036, OR = 2.99 in dominant model) in intron and a haplotype unique to this variant (CACNG6_BL1_ht6; P = 0.003, P corr = 0.02, OR = 2.57 in co-dominant model, P = 0.001, P corr = 0.0087, OR = 2.81 in dominant model) were significantly associated with the risk of AIA. Conclusions: Our results suggest that the CACNG6 variants might be associated with the risk of AIA in a Korean population.

1 January 2009 in Journal of Asthma
Verified
Journal Article
Closed access
EHEui-Ryoung Han
Eui-Ryoung Han
ICInseon S. Choi
Inseon S. Choi
HKHee-Kyung Kim
Hee-Kyung Kim
YKYong-Woon Kang
Yong-Woon Kang
JPJin-Gyoon Park
Jin-Gyoon Park
JCJong-Hun Choi
Jong-Hun Choi
The recent Global Initiative for Asthma guideline states that inhaled corticosteroids (ICSs) may induce osteoporosis as a systemic adverse effect. New ICSs, such as fluticasone propionate, have a high topical potency and may therefore induce tooth problems as a result of direct exposure without hepatic metabolism more frequently than older ICSs. We evaluated asthma patients who underwent long-term treatment with a new ICS to determine if they had tooth problems that were related to osteoporosis of the mandible. When the conventional bone mineral density (BMD) of asthmatics that received the ICS treatment for at least one year was measured using dual-energy X-ray absorptiometry, the BMD of the mandible was also measured. The T-score of the mandible BMD was then determined based on the mean BMD +/- the standard deviation of normal young adults. Asthma patients with tooth loss (n = 36) and with caries or other tooth problems (n = 28) were found to have a significantly higher prevalence of osteoporosis in the mandible than those without tooth problems (n = 17; 22.2%, 7.1%, 0%, respectively; chi(2) = 6.34, p < 0.05). In addition, the presence of mandibular osteoporosis (odds ratio: 6.14, p = 0.02) and a T-score of < -1.0 for the femoral neck (odds ratio: 3.25, p = 0.01) were found to be significant risk factors for tooth loss in the asthma patients. Finally, the T-score of the mandible was found to be correlated with age (r = -0.316, p < 0.01), and with the T-scores of the lumbar spine (r = 0.413, p < 0.001) and femoral neck (r = 0.446, p < 0.001). Tooth loss in asthma patients undergoing long-term treatment with a topically potent ICS was found to be related to a decrease in BMD, especially in the mandible. Therefore, patients using these types of ICS should have their mandibular BMD checked regularly, especially if they have any risk factors for osteoporosis. In addition, it would be wise for such patients to reduce their ICS dose.